Moloney Securities Asset Management, LLC Amgen Inc Transaction History

Moloney Securities Asset Management, LLC

$664 Million
Q1 2025

A detailed history of Moloney Securities Asset Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Moloney Securities Asset Management, LLC holds 17,281 shares of AMGN stock, worth $5.07 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares

17,281

Previous 13,927 24.08%

Holding current value

$5.07 Million

Previous $3.63 Million 48.33%

% of portfolio

0.81%

Previous 0.51%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 30, 2025	BUY	$258.59 - $327.36 $867,310 - $1.1 Million	3,354 Added 24.08%	17,281 $5.38 Million
Q4 2024 Jan 28, 2025	SELL	$258.78 - $328.31 $67,024 - $85,032	-259 Reduced 1.83%	13,927 $3.63 Million
Q3 2024 Oct 30, 2024	SELL	$309.38 - $337.38 $286,485 - $312,413	-926 Reduced 6.13%	14,186 $4.57 Million
Q2 2024 Jul 30, 2024	SELL	$262.75 - $319.31 $609,580 - $740,799	-2,320 Reduced 13.31%	15,112 $4.72 Million
Q1 2024 May 01, 2024	BUY	$268.87 - $324.56 $369,427 - $445,945	1,374 Added 8.56%	17,432 $4.96 Million
Q4 2023 Jan 30, 2024	SELL	$255.7 - $288.46 $42,190 - $47,595	-165 Reduced 1.02%	16,058 $4.63 Million
Q3 2023 Oct 31, 2023	SELL	$218.65 - $271.46 $3,717 - $4,614	-17 Reduced 0.1%	16,223 $4.36 Million
Q2 2023 Jul 31, 2023	BUY	$214.27 - $253.37 $502,248 - $593,899	2,344 Added 16.87%	16,240 $3.61 Million
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $384,068 - $468,115	-1,701 Reduced 10.91%	13,896 $3.36 Million
Q4 2022 Jan 30, 2023	SELL	$229.03 - $291.01 $85,886 - $109,128	-375 Reduced 2.35%	15,597 $4.1 Million
Q3 2022 Oct 31, 2022	SELL	$224.46 - $253.15 $17,732 - $19,998	-79 Reduced 0.49%	15,972 $3.6 Million
Q2 2022 Aug 03, 2022	SELL	$230.71 - $256.74 $113,509 - $126,316	-492 Reduced 2.97%	16,051 $3.91 Million
Q1 2022 May 10, 2022	BUY	$219.27 - $242.57 $338,114 - $374,042	1,542 Added 10.28%	16,543 $4 Million
Q4 2021 Jan 28, 2022	SELL	$198.88 - $227.6 $57,078 - $65,321	-287 Reduced 1.88%	15,001 $3.38 Million
Q3 2021 Oct 27, 2021	BUY	$212.27 - $248.7 $131,182 - $153,696	618 Added 4.21%	15,288 $3.25 Million
Q2 2021 Jul 26, 2021	BUY	$233.58 - $259.14 $148,089 - $164,294	634 Added 4.52%	14,670 $3.58 Million
Q1 2021 Apr 28, 2021	SELL	$221.91 - $258.6 $383,238 - $446,602	-1,727 Reduced 10.96%	14,036 $3.49 Million
Q4 2020 Feb 08, 2021	SELL	$216.38 - $257.67 $163,150 - $194,283	-754 Reduced 4.56%	15,763 $3.62 Million
Q3 2020 Oct 20, 2020	BUY	$234.65 - $260.95 $281,110 - $312,618	1,198 Added 7.82%	16,517 $4.2 Million
Q2 2020 Jul 31, 2020	BUY	$197.81 - $242.74 $25,517 - $31,313	129 Added 0.85%	15,319 $3.61 Million
Q1 2020 May 08, 2020	BUY	$182.24 - $241.7 $629,092 - $834,348	3,452 Added 29.41%	15,190 $3.08 Million
Q4 2019 Feb 06, 2020	BUY	$189.21 - $243.2 $152,881 - $196,505	808 Added 7.39%	11,738 $2.83 Million
Q3 2019 Nov 01, 2019	BUY	$174.11 - $208.62 $2,089 - $2,503	12 Added 0.11%	10,930 $2.12 Million
Q2 2019 Jul 29, 2019	SELL	$166.7 - $195.41 $4,500 - $5,276	-27 Reduced 0.25%	10,918 $2.01 Million
Q1 2019 May 03, 2019	BUY	$180.87 - $203.88 $169,656 - $191,239	938 Added 9.37%	10,945 $2.08 Million
Q4 2018 Feb 11, 2019	SELL	$178.4 - $208.25 $49,416 - $57,685	-277 Reduced 2.69%	10,007 $1.95 Million
Q3 2018 Oct 24, 2018	SELL	$185.29 - $208.89 $10,561 - $11,906	-57 Reduced 0.55%	10,284 $0
Q2 2018 Jul 26, 2018	BUY	$166.05 - $186.51 $133,670 - $150,140	805 Added 8.44%	10,341 $1.91 Million
Q1 2018 Apr 25, 2018	SELL	$169.43 - $198.0 $63,027 - $73,656	-372 Reduced 3.75%	9,536 $1.63 Million
Q4 2017 Jan 25, 2018	SELL	$168.79 - $188.59 $96,716 - $108,062	-573 Reduced 5.47%	9,908 $1.72 Million
Q3 2017 Oct 18, 2017	BUY	$167.29 - $191.0 $1.75 Million - $2 Million	10,481	10,481 $1.95 Million

Others Institutions Holding AMGN

# of Institutions

3,310

Shares Held

429M

Call Options Held

8.06M

Put Options Held

7.7M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $157B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moloney Securities Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moloney Securities Asset Management, LLC with notifications on news.

Account

Moloney Securities Asset Management, LLC Amgen Inc Transaction History